26.29 USD
↘ 0.65 (2.41%)PRE MARKET (AS OF 04:26 AM EDT)
Zenas BioPharma, Inc. Common Stock
ZBIONASDAQ • USD
Market: OPEN
Zenas BioPharma, Inc. Common Stock (ZBIO) trades at $26.29 per share. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Furthermore, ZBIO is currently richly valued, trading at a premium to sector peers across key valuation metrics.
Technical & fundamental data as of Oct 6, 2026.
Open?$26.29
High?$26.29
Low?$26.29
Prev. Close?$26.94
Volume?1
Avg. Volume?692.4K
VWAP?$26.29
Rel. Volume?0.00x
Bid / Ask
Bid?$22.87 × 100
Ask?$34.20 × 100
Spread?$11.33
Midpoint?$28.54
Valuation & Ratios
Market Cap?1.8B
Shares Out?65.2M
Float?31.2M
Float %?47.8%
P/E Ratio?N/A
P/B Ratio?7.11
EPS?-$7.43
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them. The Company manages its operations on a consolidated basis as a single reportable segment focused on the research, development and commercialization of transformative immunology-based therapies.
Employees
167
Market Cap
1.8B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2024-09-13
Address
852 WINTER STREET, SUITE 250
WALTHAM, MA 02451
Phone: 857-271-2954
WALTHAM, MA 02451
Phone: 857-271-2954
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?1
Momentum?50
Short Sent.?10
Piotroski F-Score?0/9Weak
Altman Z-Score?-0.82Distress
Confidence?53%Low
Short InterestSqueeze Risk
Short % of Float?38.10%Squeeze Risk
Short Interest?11.9M
Days to Cover?22.4
Free Float31.2M
Avg Daily Volume529.3K
Settlement Date2026-09-15
Financial Health
Current Ratio?9.93Strong
Quick Ratio?9.93Strong
Cash Ratio?2.99Strong
Debt/Equity?1.20Moderate
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score58/100
P/E?N/A▾
P/B?7.11FAIR▾
Peers100
S&P26
P/S?1,755.86HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-3.9CHEAP▾
S&P97
EV/Sales?1,856.30HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-196.0%WEAK▾
S&P3
ROA?-69.0%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-225974000
Enterprise Value?$1.9B
Fundamentals ratios updated end of day